Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atroposelective Negishi Coupling Optimization Guided by Multivariate Linear Regression Analysis: Asymmetric Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
Jie Xu, Samantha Grosslight, Kyle A. Mack, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 45, pp. 20955-20963
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 38
Dynamic Kinetic Reductive Grignard-Type Addition for the Construction of Axial and Central Chirality
Ya-Ping Shao, Yong‐Min Liang
ACS Catalysis (2025), pp. 1147-1157
Closed Access | Times Cited: 4
Dataset Design for Building Models of Chemical Reactivity
Priyanka Raghavan, Brittany C. Haas, Madeline E. Ruos, et al.
ACS Central Science (2023) Vol. 9, Iss. 12, pp. 2196-2204
Open Access | Times Cited: 38
Atroposelective catalysis
Tanno A. Schmidt, Valeriia Hutskalova, Christof Sparr
Nature Reviews Chemistry (2024) Vol. 8, Iss. 7, pp. 497-517
Closed Access | Times Cited: 16
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
Xiaoshen Ma, David L. Sloman, Ruchia Duggal, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11024-11052
Closed Access | Times Cited: 12
Virtual Ligand Strategy in Transition Metal Catalysis Toward Highly Efficient Elucidation of Reaction Mechanisms and Computational Catalyst Design
Wataru Matsuoka, Yu Harabuchi, Satoshi Maeda
ACS Catalysis (2023) Vol. 13, Iss. 8, pp. 5697-5711
Open Access | Times Cited: 19
A Customized Bayesian Algorithm to Optimize Enzyme-Catalyzed Reactions
Ryo Tachibana, Kailin Zhang, Zhi Zou, et al.
ACS Sustainable Chemistry & Engineering (2023) Vol. 11, Iss. 33, pp. 12336-12344
Open Access | Times Cited: 17
A genetic optimization strategy with generality in asymmetric organocatalysis as a primary target
Simone Gallarati, Puck van Gerwen, Rubén Laplaza, et al.
Chemical Science (2024) Vol. 15, Iss. 10, pp. 3640-3660
Open Access | Times Cited: 7
Computationally Guided Ligand Discovery from Compound Libraries and Discovery of a New Class of Ligands for Ni-Catalyzed Cross-Electrophile Coupling of Challenging Quinoline Halides
Sergei Tcyrulnikov, Aran K. Hubbell, Dylan J. Pedro, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 10, pp. 6947-6954
Closed Access | Times Cited: 6
In-silico-assisted derivatization of triarylboranes for the catalytic reductive functionalization of aniline-derived amino acids and peptides with H2
Yusei Hisata, Takashi Washio, Shinobu Takizawa, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
Jie Xu, Ngiap‐Kie Lim, Jacob C. Timmerman, et al.
Organic Letters (2023) Vol. 25, Iss. 19, pp. 3417-3422
Closed Access | Times Cited: 15
Development of a Streamlined Manufacturing Process for the Highly Substituted Quinazoline Core Present in KRAS G12C Inhibitor Divarasib
Johannes A. Burkhard, Sebastian Herold, Christian Leitner, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 1, pp. 102-111
Closed Access | Times Cited: 4
Automated approaches, reaction parameterisation, and data science in organometallic chemistry and catalysis: towards improving synthetic chemistry and accelerating mechanistic understanding
Stuart C. Smith, Christopher S. Horbaczewskyj, Theo F. N. Tanner, et al.
Digital Discovery (2024) Vol. 3, Iss. 8, pp. 1467-1495
Open Access | Times Cited: 4
COBRA web application to benchmark linear regression models for catalyst optimization with few-entry datasets
Zhen Cao, Laura Falivene, Albert Poater, et al.
Cell Reports Physical Science (2024), pp. 102348-102348
Open Access | Times Cited: 4
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie International Edition (2025)
Open Access
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie (2025)
Open Access
Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L)1 therapy: a systematic review
Fan Zhang, Banglu Wang, Menghuan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry
Sean M. Kelly, René Lebl, Thomas C. Malig, et al.
Organic Process Research & Development (2023)
Closed Access | Times Cited: 9
Highly chemoselective ligands for Suzuki–Miyaura cross-coupling reaction based on virtual ligand-assisted screening
Wataru Matsuoka, Yu Harabuchi, Yuuya Nagata, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 15, pp. 3132-3142
Open Access | Times Cited: 7
Computational methods for asymmetric catalysis
Sharon Pinus, Jérôme Genzling, Mihai Burai Patrascu, et al.
Nature Catalysis (2024)
Closed Access | Times Cited: 2
Scalable Atroposelective Synthesis of MRTX1719: An Inhibitor of the PRMT5/MTA Complex
Michał Achmatowicz, Thomas Scattolin, David R. Snead, et al.
Organic Process Research & Development (2023) Vol. 27, Iss. 5, pp. 954-971
Open Access | Times Cited: 6
Manufacturing Process for 6-Bromo-N,N-bis(4-methoxybenzyl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine, a Key Intermediate in the Synthesis of KRAS G12C Inhibitor Divarasib
Jeff Shen, Nicholas A. White, Qingping Tian, et al.
Organic Process Research & Development (2023) Vol. 28, Iss. 1, pp. 92-101
Closed Access | Times Cited: 6
Deconvoluting Nonlinear Catalyst–Substrate Effects in the Intramolecular Dirhodium-Catalyzed C–H Insertion of Donor/Donor Carbenes Using Data Science Tools
Lucas W. Souza, Beck Miller, Ryan C. Cammarota, et al.
ACS Catalysis (2023) Vol. 14, Iss. 1, pp. 104-115
Open Access | Times Cited: 5
High Resolution Ion Mobility Enables the Structural Characterization of Atropisomers of GDC-6036, a KRAS G12C Covalent Inhibitor
Marcelino Varona, Daniel P. Dobson, José G. Napolitano, et al.
Journal of the American Society for Mass Spectrometry (2024) Vol. 35, Iss. 11, pp. 2586-2595
Closed Access | Times Cited: 1
Organopalladium Catalysis as a Proving Ground for Data-Rich Approaches to Reaction Development and Quantitative Predictions
Jingru Lu, David C. Leitch
ACS Catalysis (2023) Vol. 13, Iss. 24, pp. 15691-15707
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top